Clinical Trial Update: SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating switching from Atripla to Eviplera in HIV patients without central nervous system symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Eviplera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 4 | Status: COMPLETED